Fate Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

페이트 테라퓨틱스NASDAQ:FATE · Nasdaq · Healthcare

$2.32+0.87%

2026-10-02 close

Fate Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $14M. 2024 operating profit was −$210M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy